Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: MAPK4 deletion enhances radiation effects and triggers synergistic lethality with simultaneous PARP1 inhibition in cervical cancer

Fig. 1

MAPK4 mRNA level is associated with the overall survival of cervical cancer patients. a Relative MAPK4 mRNA levels in tissues of cervical cancer patients at stage I (n = 28) or stage II (n = 32), as determined using qRT-PCR. b Relative MAPK4 mRNA levels in cervical cancer tissues (tumor, n = 60) and normal adjacent tissues (non-tumor, n = 60), as determined using qRT-PCR. c Overall survival curve analysis of 60 cervical cancer patients using Kaplan-Meier method, stratified by MAPK4 mRNA expression. Data are expressed as the mean ± SEM

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us